FDA Clearance Tracker · P980053-S003
DURASPHERE INJECTABLE BULKING AGENT
Last checked: Nov 20, 2026Latest source record: Apr 2, 2001 (this decision)Source: openFDAMethods & limitations
Decided
Apr 2, 2001
Approved
Time to decision
21 days
Received Mar 12, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P980053-S003
- Device name
- DURASPHERE INJECTABLE BULKING AGENT
- Applicant
- Carbon Medical Technologies, Inc.
- Applicant location
- St. Paul, MN
- Received
- Mar 12, 2001
- Decided
- Apr 2, 2001
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P980053
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
APPROVAL TO REVISE LABELING'S DIRECTIONS FOR USE TO ADD INSTRUCTIONS FOR INJECTION OF DURASPHERE(R) VIA A PERIURETHRAL ROUTE.
Source documents
Other decisions for Carbon Medical Technologies, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253598 · Decided Mar 31, 2026 · 133 days after receipt
Device type: Endoscopic Injection Needle, Gastroenterology-Urology (FBK) · GI, Urology & Nephrology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.